HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Bellon, A. Articles by Vey, M. Search for Related Content PubMed PubMed Citation Articles by Bellon, A. Articles by Vey, M. Agricola Articles by Bellon, A. Articles by Vey, M.

Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity

¹ Virology, Aventis Behring GmbH, PO Box 1230, 35002 Marburg, Germany
² Industry and Health Policy, Aventis Behring SA, 46 Quai de la Rapée, 75601 Paris Cedex 12, France

Correspondence
Albrecht Gröner
albrecht.groener{at}aventis.com

The presence of pathogenic prion protein (PrP^Sc) in lymphoid tissues of variant Creutzfeldt–Jakob disease (vCJD) patients raises questions as to whether prions may be present in bodily fluids as well. Currently, transgenic mice are highly sensitive in vivo tools for the study of prions in tissues or fluids containing high levels of normal prion protein (PrP^C). We report here an in vitro assay with virtually equivalent sensitivity incorporating a capture antibody into a sandwich conformation-dependent immunoassay (CDI), resulting in 30- to 100-fold increased sensitivity compared with the original, direct CDI. Furthermore, spiking plasma with vCJD prions in different preparations demonstrated that sandwich CDI detects prions with different biophysical properties at high sensitivity, even without proteinase K pretreatment of samples. Thus, sandwich CDI represents a powerful tool to study prions in bodily fluids of CJD/vCJD patients, with a turnaround time of less than 24 h.

This article has been cited by other articles:

				P. C. Lourenco, M. J. Schmerr, I. MacGregor, R. G. Will, J. W. Ironside, and M. W. Head Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease. J. Gen. Virol., October 1, 2006; 87(Pt 10): 3119 - 3124. [Abstract] [Full Text] [PDF]

				V. Novitskaya, N. Makarava, A. Bellon, O. V. Bocharova, I. B. Bronstein, R. A. Williamson, and I. V. Baskakov Probing the Conformation of the Prion Protein within a Single Amyloid Fibril Using a Novel Immunoconformational Assay J. Biol. Chem., June 2, 2006; 281(22): 15536 - 15545. [Abstract] [Full Text] [PDF]

				O. A. Maximova, R. E. Taffs, K. L. Pomeroy, P. Piccardo, and D. M. Asher Computerized Morphometric Analysis of Pathological Prion Protein Deposition in Scrapie-Infected Hamster Brain J. Histochem. Cytochem., January 1, 2006; 54(1): 97 - 107. [Abstract] [Full Text] [PDF]

				J. G. Safar, M. D. Geschwind, C. Deering, S. Didorenko, M. Sattavat, H. Sanchez, A. Serban, M. Vey, H. Baron, K. Giles, et al. Diagnosis of human prion disease PNAS, March 1, 2005; 102(9): 3501 - 3506. [Abstract] [Full Text] [PDF]

				P. Minor, J. Newham, N. Jones, C. Bergeron, L. Gregori, D. Asher, F. van Engelenburg, T. Stroebel, M. Vey, G. Barnard, et al. Standards for the assay of Creutzfeldt-Jakob disease specimens J. Gen. Virol., June 1, 2004; 85(6): 1777 - 1784. [Abstract] [Full Text] [PDF]